The historic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its legacy within the broader industry now triggers questions about long-term yields . Generic versions are undercutting exclusivity , leading to anxieties that investing in companies significantly dependent to Viagra's previous standing could be a specula